Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data.
Saved in:
| Title: | Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data. |
|---|---|
| Authors: | Jolly RA; Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN, 46285, USA. Electronic address: jolly_robert_a@lilly.com., Trejo-Martin A; Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, 333 Lakeside Drive, Foster City, CA, 94404, USA., Bercu JP; Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, 333 Lakeside Drive, Foster City, CA, 94404, USA., Powley MW; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA., Tennant RE; Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK., Ponting DJ; Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK., Nudelman R; Nudelman ChemTox Consulting Ltd.15 Miller St, Rehovot, 7628422, Israel., Sobol Z; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA., Czich A; Sanofi, R&D Translational Medicine Preclinical Safety, D-69526, Frankfurt, DE, Germany., Johnson GE; Swansea University Medical School, Swansea University, Swansea, Wales, UK., Yang Y; AbbVie Inc., Global Preclinical Safety, North Chicago, IL, 60064, USA., Kobets T; New York Medical College, Department of Pathology, Microbiology and Immunology, Valhalla, NY, 10595, USA., White PA; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, CA, USA., Minocherhomji S; Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN, 46285, USA., Lynch AM; GSK, Genetic and Investigative Toxicology, Stevenage, Herts, SG1 2NY, UK., Zeller A; Pharmaceutical Sciences, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Ott GR; Teva Pharmaceuticals, West Chester, PA, 19380, USA., Escobar PA; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA., Hobbs C; Inotiv, Rockville, MD, 20850, USA., Schuler M; Pfizer Research, Development, and Medical, Groton, CT, 06370, USA., Chen CL; Health and Environmental Sciences Institute, Washington, DC, 20005, USA., Puglisi R; Health and Environmental Sciences Institute, Washington, DC, 20005, USA. |
| Source: | Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2026 May; Vol. 167, pp. 106051. Date of Electronic Publication: 2026 Jan 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214983 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0295 (Electronic) Linking ISSN: 02732300 NLM ISO Abbreviation: Regul Toxicol Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41621793 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jolly+RA%22">Jolly RA</searchLink>; Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN, 46285, USA. Electronic address: jolly&#95;robert&#95;a@lilly.com.<br /><searchLink fieldCode="AU" term="%22Trejo-Martin+A%22">Trejo-Martin A</searchLink>; Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, 333 Lakeside Drive, Foster City, CA, 94404, USA.<br /><searchLink fieldCode="AU" term="%22Bercu+JP%22">Bercu JP</searchLink>; Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, 333 Lakeside Drive, Foster City, CA, 94404, USA.<br /><searchLink fieldCode="AU" term="%22Powley+MW%22">Powley MW</searchLink>; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA.<br /><searchLink fieldCode="AU" term="%22Tennant+RE%22">Tennant RE</searchLink>; Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.<br /><searchLink fieldCode="AU" term="%22Ponting+DJ%22">Ponting DJ</searchLink>; Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.<br /><searchLink fieldCode="AU" term="%22Nudelman+R%22">Nudelman R</searchLink>; Nudelman ChemTox Consulting Ltd.15 Miller St, Rehovot, 7628422, Israel.<br /><searchLink fieldCode="AU" term="%22Sobol+Z%22">Sobol Z</searchLink>; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA.<br /><searchLink fieldCode="AU" term="%22Czich+A%22">Czich A</searchLink>; Sanofi, R&D Translational Medicine Preclinical Safety, D-69526, Frankfurt, DE, Germany.<br /><searchLink fieldCode="AU" term="%22Johnson+GE%22">Johnson GE</searchLink>; Swansea University Medical School, Swansea University, Swansea, Wales, UK.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; AbbVie Inc., Global Preclinical Safety, North Chicago, IL, 60064, USA.<br /><searchLink fieldCode="AU" term="%22Kobets+T%22">Kobets T</searchLink>; New York Medical College, Department of Pathology, Microbiology and Immunology, Valhalla, NY, 10595, USA.<br /><searchLink fieldCode="AU" term="%22White+PA%22">White PA</searchLink>; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, CA, USA.<br /><searchLink fieldCode="AU" term="%22Minocherhomji+S%22">Minocherhomji S</searchLink>; Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN, 46285, USA.<br /><searchLink fieldCode="AU" term="%22Lynch+AM%22">Lynch AM</searchLink>; GSK, Genetic and Investigative Toxicology, Stevenage, Herts, SG1 2NY, UK.<br /><searchLink fieldCode="AU" term="%22Zeller+A%22">Zeller A</searchLink>; Pharmaceutical Sciences, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ott+GR%22">Ott GR</searchLink>; Teva Pharmaceuticals, West Chester, PA, 19380, USA.<br /><searchLink fieldCode="AU" term="%22Escobar+PA%22">Escobar PA</searchLink>; Merck & Co. Inc., Nonclinical Drug Safety, Rahway, NJ, 07065, USA.<br /><searchLink fieldCode="AU" term="%22Hobbs+C%22">Hobbs C</searchLink>; Inotiv, Rockville, MD, 20850, USA.<br /><searchLink fieldCode="AU" term="%22Schuler+M%22">Schuler M</searchLink>; Pfizer Research, Development, and Medical, Groton, CT, 06370, USA.<br /><searchLink fieldCode="AU" term="%22Chen+CL%22">Chen CL</searchLink>; Health and Environmental Sciences Institute, Washington, DC, 20005, USA.<br /><searchLink fieldCode="AU" term="%22Puglisi+R%22">Puglisi R</searchLink>; Health and Environmental Sciences Institute, Washington, DC, 20005, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228214983%22">Regulatory toxicology and pharmacology : RTP</searchLink> [Regul Toxicol Pharmacol] 2026 May; Vol. 167, pp. 106051. <i>Date of Electronic Publication: </i>2026 Jan 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8214983 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-0295 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202732300%22">02732300 </searchLink><i>NLM ISO Abbreviation: </i>Regul Toxicol Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41621793 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.yrtph.2026.106051 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 106051 Titles: – TitleFull: Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jolly RA – PersonEntity: Name: NameFull: Trejo-Martin A – PersonEntity: Name: NameFull: Bercu JP – PersonEntity: Name: NameFull: Powley MW – PersonEntity: Name: NameFull: Tennant RE – PersonEntity: Name: NameFull: Ponting DJ – PersonEntity: Name: NameFull: Nudelman R – PersonEntity: Name: NameFull: Sobol Z – PersonEntity: Name: NameFull: Czich A – PersonEntity: Name: NameFull: Johnson GE – PersonEntity: Name: NameFull: Yang Y – PersonEntity: Name: NameFull: Kobets T – PersonEntity: Name: NameFull: White PA – PersonEntity: Name: NameFull: Minocherhomji S – PersonEntity: Name: NameFull: Lynch AM – PersonEntity: Name: NameFull: Zeller A – PersonEntity: Name: NameFull: Ott GR – PersonEntity: Name: NameFull: Escobar PA – PersonEntity: Name: NameFull: Hobbs C – PersonEntity: Name: NameFull: Schuler M – PersonEntity: Name: NameFull: Chen CL – PersonEntity: Name: NameFull: Puglisi R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1096-0295 Numbering: – Type: volume Value: 167 Titles: – TitleFull: Regulatory toxicology and pharmacology : RTP Type: main |
| ResultId | 1 |